跳至主要内容
临床试验/NCT06918327
NCT06918327已完成不适用

The Power of Concentrated Growth Factor: A New Era in Pain Management in Third Molar Surgery

Ege University1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2017年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
49
试验地点
1
主要终点
Postoperative pain on CGF-applied and CGF free sides in bilateral impacted third molar surgery

研究概览

简要总结

The purpose of this study is to evaluate the effects of concentrated growth factor (CGF) on pain after bilateral impacted third molar surgery and to determine its contribution to the healing process.

The main question it aims to answer is:

Is CGF effective on reducing the pain in impacted third molar surgery? Researchers compare the pain on the CGF-applied and CGF free sides after impacted third molar surgery. Postoperative pain is assessed using the Visual Analogue Scale. TThe postoperative outcomes including pain are clinically assessed at different-time intervals (1-7 days).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients with bilateral, symmetrical, bone-retained (vertical, mesioangular, horizontal) impacted wisdom teeth in the mandible, regardless of gender
  • •Patients without any systemic disease
  • •Patients who have been informed about the duration, purpose and requirements of the study and who have signed the informed consent form voluntarily.

排除标准

  • •Having a disease affecting general health that requires the application of prophylactic antimicrobial agents
  • •Having a systemic viral, fungal or bacterial infection
  • •Patients with acute or chronic maxillary sinusitis
  • •Suspected or diagnosed pregnancy and nursing mothers
  • •Patients with heart and vascular diseases
  • •Patients with liver disease, haematological disease and neoplastic disease
  • •Patients who have recently received anti-inflammatory therapy
  • •Patients with chronic medication use (antihistamines, NSAIDs, steroids and antidepressants)
  • •Patients predisposed to psychotic or psychopathic tendencies
  • •Patients with rheumatic diseases, blood diseases, diabetes mellitus
  • •Patients at cardiological risk of infective endocarditis
  • •Patients under antibiotic pressure

研究组 & 干预措施

CGF

Experimental

Participants received CGF after the operation on one side

干预措施: Concentrated Growth Factor (Other)

CGF

Experimental

Participants received CGF after the operation on one side

干预措施: non-CGF (Other)

non-CGF

No Intervention

The other extraction socket is left empty

结局指标

主要结局

Postoperative pain on CGF-applied and CGF free sides in bilateral impacted third molar surgery

时间窗: The postoperative outcomes including pain are clinically assessed at different-time intervals (1st, 2nd, 3rd, 4th, 5th, 6th and 7th days).

The primary outcome measure is postoperative pain on CGF-applied and CGF free sides in bilateral impacted third molar surgery. Postoperative pain is assessed using the Visual Analogue Scale (VAS). Patients are asked to mark the pain they felt on the scale (10 cm long line) on the (1-7) days after the operation. The end of the line indicates unbearable pain, the beginning indicates no pain.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mert Zeytinoğlu

Assoc. Prof. Dr.

Ege University

研究点 (1)

Loading locations...

相似试验